[Federal Register Volume 84, Number 190 (Tuesday, October 1, 2019)]
[Notices]
[Page 52135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21313]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Registration; Siemens 
Healthcare Diagnostics, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
a registration by the Drug Enforcement Administration (DEA) as a bulk 
manufacturer of various classes of schedule I and II controlled 
substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as a bulk manufacturer of a basic class of schedule I and II 
controlled substances. Information on previously published notices is 
listed below. No comments or objections were submitted for the notice.

------------------------------------------------------------------------
           Company                FR Docket             Published
------------------------------------------------------------------------
Siegfried USA, LLC...........  84 FR 7129.....  March 1, 2019.
Patheon Pharmaceuticals, Inc.  84 FR 8114.....  March 6, 2019.
S & B Pharma Inc.............  84 FR 8116.....  March 6, 2019.
Siemens Healthcare             84 FR 10534....  March 21, 2019.
 Diagnostics, Inc.
Synthcon, LLC................  84 FR 13962....  April 8, 2019.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of these registrants to manufacture 
the applicable basic classes of controlled substances is consistent 
with the public interest and with United States obligations under 
international treaties, conventions, or protocols in effect on May 1, 
1971. The DEA investigated each of the company's maintenance of 
effective controls against diversion by inspecting and testing each 
company's physical security systems, verifying each of the company's 
compliance with state and local laws, and reviewing each company's 
background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer 
to the above listed companies.

    Dated: September 23, 2019.
Thomas W. Prevoznik,
Acting Assistant Administrator, Deputy Assistant Administrator.
[FR Doc. 2019-21313 Filed 9-30-19; 8:45 am]
 BILLING CODE 4410-09-P